News
Hogan Lovells CES 2023 Recap
15 February 2023
In January, sector focused lawyers from Hogan Lovells travelled to Las Vegas to attend CES. Our team enjoyed seeing clients in person as well as seeing the latest products and trends, and...
News
15 February 2023
In January, sector focused lawyers from Hogan Lovells travelled to Las Vegas to attend CES. Our team enjoyed seeing clients in person as well as seeing the latest products and trends, and...
News
07 September 2022
To date, employee data has been largely exempt from the requirements of the California Consumer Privacy Act of 2018 (CCPA). However, effective January 1, 2023, the Consumer Privacy...
News
28 July 2022
California’s Pharmaceutical and Sharps Waste Stewardship Act requires pharmaceutical companies doing business in the state to develop and submit a “stewardship plan”...
News
03 May 2022
Being an innovative business comes with its challenges and legal risks. In recent years, there has been a major increase in cyber attacks, and this is a real risk for every business. ...
News
23 August 2021
Under FDA's leadership, the International Council for Harmonisation (ICH) recently published Q13 draft guidelines on continuous manufacturing (CM) to advance the brand and generic drug...
News
14 May 2021
The U.S. Food and Drug Administration’s (FDA) commitment to expand mutual reliance with trusted regulatory partners may be a silver lining for biomedical innovation during an...
News
15 April 2021
On April 14, the U.S. Food and Drug Administration (FDA) released the immediately-in-effect guidance “Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring...
Media Mention
24 February 2021
In a recent report produced by Private Equity International, Ed Harris and Adam Brown comment on the expanding GP-led secondaries market, including restructurings, continuation funds and...